Insider Transactions in Q4 2021 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+18.13%
|
$0
$0.35 P/Share
|
|
Dec 01
2021
|
Eric Bjerkholt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,750
-21.77%
|
$92,000
$16.02 P/Share
|
|
Dec 01
2021
|
Eric Bjerkholt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,414
+38.33%
|
-
|
|
Nov 15
2021
|
Srinivas Akkaraju Director |
BUY
Open market or private purchase
|
Indirect |
1,215,000
+20.92%
|
$17,010,000
$14.0 P/Share
|
|
Nov 10
2021
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,230
-4.42%
|
$93,450
$15.48 P/Share
|
|
Nov 09
2021
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-54.98%
|
$65,000
$13.53 P/Share
|
|
Nov 09
2021
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+21.56%
|
$0
$0.35 P/Share
|
|
Nov 08
2021
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,770
-8.91%
|
$206,550
$15.17 P/Share
|
|
Nov 05
2021
|
Tom Frohlich Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.86%
|
$280,000
$14.0 P/Share
|
|
Nov 05
2021
|
Tom Frohlich Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.91%
|
$0
$0.42 P/Share
|
|
Oct 21
2021
|
William Mariner Greenman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,663
+7.18%
|
$3,326
$2.6 P/Share
|
|
Oct 06
2021
|
Alan Glicklich Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,489
-35.04%
|
$29,868
$12.37 P/Share
|
|
Oct 06
2021
|
Alan Glicklich Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,103
+50.0%
|
-
|
|
Oct 06
2021
|
Andrew James King Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,557
-35.04%
|
$42,684
$12.37 P/Share
|
|
Oct 06
2021
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,151
+50.0%
|
-
|
|
Oct 06
2021
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,796
+17.96%
|
-
|
|
Oct 06
2021
|
Tom Frohlich Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,359
-4.41%
|
$88,308
$12.37 P/Share
|
|
Oct 06
2021
|
Tom Frohlich Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,580
+7.52%
|
-
|